Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?
出版信息
Intensive Care Med. 2021 Jul;47(7):733-736. doi: 10.1007/s00134-021-06409-y. Epub 2021 Jun 16.
Abstract
摘要
相似文献
1
Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?减轻全球脓毒症负担：这会是新冠疫情留下的一项积极遗产吗？
Intensive Care Med. 2021 Jul;47(7):733-736. doi: 10.1007/s00134-021-06409-y. Epub 2021 Jun 16.
2
What Sepsis Researchers Can Learn from COVID-19.脓毒症研究人员能从新冠病毒病中学到什么。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):125-127. doi: 10.1164/rccm.202010-4023LE.
3
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.中亚地区 SARS-CoV-2 传播的监测指标：纵向趋势分析。
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.
4
COVID-19 Pandemic: What Have We Learned?COVID-19 大流行：我们从中吸取了哪些教训？
Clin J Oncol Nurs. 2021 Feb 1;25(1):11-12. doi: 10.1188/21.CJON.11-12.
5
Pandemic preparedness and response to COVID-19 in South Asian countries.南亚国家应对 COVID-19 大流行的准备和应对。
Int J Infect Dis. 2021 Mar;104:169-174. doi: 10.1016/j.ijid.2020.12.048. Epub 2020 Dec 25.
6
Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.在大流行前和大流行期间的患者人群中对两种自动化抗 SARS-CoV-2 免疫分析的分析和临床分析。
J Appl Lab Med. 2021 Mar 1;6(2):441-450. doi: 10.1093/jalm/jfaa204.
7
The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?新型冠状病毒病 2019 大流行：它如何传播，我们如何阻止它？
Curr Opin HIV AIDS. 2020 Nov;15(6):328-335. doi: 10.1097/COH.0000000000000650.
8
A COVID-19 vaccine-dare to dream.一种新冠疫苗——敢于梦想。
Br J Community Nurs. 2020 Dec 2;25(12):2-7. doi: 10.12968/bjcn.2020.25.12.598.
9
Preventing the next pandemic: the power of a global viral surveillance network.预防下一次大流行：建立全球病毒监测网络的力量。
BMJ. 2021 Mar 12;372:n485. doi: 10.1136/bmj.n485.
10
Reflections for global public health research and evidence-based medicine during the COVID-19 pandemic.新冠疫情期间对全球公共卫生研究和循证医学的思考
S Afr Med J. 2020 Sep 28;110(11):1070-1071.
引用本文的文献
1
Digital solutions in paediatric sepsis: current state, challenges, and opportunities to improve care around the world.儿科脓毒症中的数字化解决方案：当前状况、挑战和改善全球医疗的机遇。
Lancet Digit Health. 2024 Sep;6(9):e651-e661. doi: 10.1016/S2589-7500(24)00141-9. Epub 2024 Aug 12.
2
Empowering excellence in intensive care: a vision for the European Society of Intensive Care Medicine.助力重症监护卓越发展：欧洲重症监护医学学会的愿景
Intensive Care Med. 2024 Jul;50(7):1129-1132. doi: 10.1007/s00134-024-07484-7. Epub 2024 Jun 3.
3
Mortality for Time-Sensitive Conditions at Urban vs Rural Hospitals During the COVID-19 Pandemic.新冠疫情期间城市与农村医院对时间敏感型病症的死亡率
JAMA Netw Open. 2024 Mar 4;7(3):e241838. doi: 10.1001/jamanetworkopen.2024.1838.
4
Decrease in Mortality after the Implementation of a Hospital Model to Improve Performance in Sepsis Care: Princess Sepsis Code.实施医院模式以改善脓毒症护理绩效后的死亡率下降：公主脓毒症代码。
J Pers Med. 2024 Jan 29;14(2):149. doi: 10.3390/jpm14020149.
5
Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control.脓毒症，呼吁将其纳入欧洲疾病预防控制中心的工作计划。
Intensive Care Med. 2023 Sep;49(9):1138-1142. doi: 10.1007/s00134-023-07127-3. Epub 2023 Aug 1.
6
Supporting Clinical Care: SOFA on FHIR.支持临床护理：基于FHIR的序贯器官衰竭评估（SOFA）
AMIA Jt Summits Transl Sci Proc. 2023 Jun 16;2023:234-243. eCollection 2023.
7
Swiss Sepsis National Action Plan: A coordinated national action plan to stop sepsis-related preventable deaths and to improve the support of people affected by sepsis in Switzerland.瑞士脓毒症国家行动计划：一项旨在阻止与脓毒症相关的可预防死亡，并改善对瑞士脓毒症患者支持的全国性协调行动计划。
Front Med (Lausanne). 2023 Feb 20;10:1114546. doi: 10.3389/fmed.2023.1114546. eCollection 2023.
8
"Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?": Comment from Seitz et al.“新冠病毒感染中的血栓炎症：α2巨球蛋白能否帮助控制病情？”：来自塞茨等人的评论
J Thromb Haemost. 2023 Mar;21(3):704-705. doi: 10.1016/j.jtha.2023.01.005.
9
Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms.应对2019年重症冠状病毒病中的脓毒症挑战：战斗的号角
Open Forum Infect Dis. 2022 Dec 1;10(1):ofac645. doi: 10.1093/ofid/ofac645. eCollection 2023 Jan.
10
Immunologic response in bacterial sepsis is different from that in COVID-19 sepsis.细菌性脓毒症中的免疫反应与新冠病毒感染所致脓毒症中的免疫反应不同。
Infection. 2022 Aug;50(4):1035-1037. doi: 10.1007/s15010-022-01803-0. Epub 2022 Mar 18.
本文引用的文献
1
Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.COVID-19给美国临床研究事业带来的新教训。
JAMA. 2021 Mar 23;325(12):1159-1161. doi: 10.1001/jama.2021.3284.
2
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.COVID-19、免疫血栓形成和静脉血栓栓塞症：生物学机制。
Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6.
Zotero 插件